Skip to Content
ETFs

Franklin Genomic Advancements ETF

HELX
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Feb 25 2020
Expense Ratio
0.50%
Type
Global Equities
Fund Owner
Franklin Templeton
Volume (1m avg. daily)
$13,400
AUM
$8,484,000
Associated Index
None
Inverse/Leveraged
No
Passive/Active
Active
Fractionable on Composer
No
Prospectus
View

Top 10 Holdings

TMO
Thermo Fisher Scientific Inc.
6.22%
DHR
Danaher Corp.
6.09%
MEDP
Medpace Holdings Inc
5.55%
RGEN
Repligen Corp.
5.17%
VRTX
Vertex Pharmaceuticals, Inc.
4.24%
REGN
Regeneron Pharmaceuticals, Inc.
4.10%
SRT3
Sartorius AG - PRF PERPETUAL EUR
3.20%
207940
Samsung Biologics Co Ltd
3.03%
KRYS
Krystal Biotech Inc
2.96%
CTVA
Corteva Inc
2.78%
Invest with HELX

What is HELX?

The Fund invests at least 80% of its net assets in equity securities of companies that are relevant to the Fund s investment theme of genomic advancements. The Fund invests predominantly in common stock. The Fund s investment theme of genomic advancements are those that the investment manager believes are substantially focused on and/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business, such as by offering new products or services that rely on genetic engineering, gene therapy, genome analysis, DNA sequencing, synthesis or instrumentation. These companies may include those that research, develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and diagnostics, pharmaceuticals and agricultural applications of genomics, and related equipment, techniques and processes.

ETFs related toHELX

ETFs correlated to HELX include GNOM, FXH, IBB

HELX
Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF
GNOM
Global X Funds - Global X Genomics & Biotechnology ETF
FXH
First Trust Exchange-Traded Fund III - First Trust Health Care AlphaDEX Fund
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
VBK
Vanguard Group, Inc. - Vanguard Small Cap Growth ETF
QQQJ
Invesco Exchange-Traded Fund Trust II - Invesco NASDAQ Next Gen 100 ETF
RSPH
Invesco Capital Management LLC - Invesco S&P 500 Equal Weight Health Care ETF
NUMG
Nuveen Fund Advisors LLC - Nuveen ESG Mid-Cap Growth ETF
IWP
BlackRock Institutional Trust Company N.A. - iShares Russell Mid-Cap Growth ETF
VOT
Vanguard Group, Inc. - Vanguard Mid-Cap Growth ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • •Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • •Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • •Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

Automated Strategies
Related toHELX

#GLOBE

Follow the Global Trend

Category

Momentum, Lever Up, Go Global, Diversification

Risk Rating

Moderate

#PTC

Pick the Trending Commodity

Category

Living With High Inflation, Ride the Momentum

Risk Rating

Moderate

Create your own algorithmic trading strategy with HELX using Composer

FAQ

HELX is a Global Equities ETF. The Fund invests at least 80% of its net assets in equity securities of companies that are relevant to the Fund s investment theme of genomic advancements. The Fund invests predominantly in common stock. The Fund s investment theme of genomic advancements are those that the investment manager believes are substantially focused on and/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business, such as by offering new products or services that rely on genetic engineering, gene therapy, genome analysis, DNA sequencing, synthesis or instrumentation. These companies may include those that research, develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and diagnostics, pharmaceuticals and agricultural applications of genomics, and related equipment, techniques and processes.

Yes, HELX is actively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

No, HELX is not passively managed. It is actively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on HELX is -0.0571%. This is the percent change in the value of HELX over the most recent 1-month period. The 3-month return on HELX is -0.054%. This is the percent change in the value of HELX over the most recent 3-month period.

The standard deviation of HELX for the past year is 0.2225%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to HELX include IXJ, SMH, and URA.

ETFs correlated to HELX include GNOM, FXH, and IBB.

ETFs that are inversely correlated to HELX include SRTY, TZA, and RWM.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.